Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 452

The DOI matches its Crossref record; 202 of the 202 references it cites were found in a registry or an index.

Carotid Intima-Media Thickness Progression as Surrogate Marker for Cardiovascular Risk: Meta-Analysis of 119 Clinical Trials Involving 100 667 Patients

Open access
Willeit, Peter, Tschiderer, Lena, Allara, Elias, Reuber, Kathrin, Seekircher, Lisa, Gao, Lu, Liao, Ximing, Lonn, Eva, Gerstein, Hertzel C., Yusuf, Salim, Brouwers, Frank P., Asselbergs, Folkert W., van Gilst, Wiek, Anderssen, Sigmund A., Grobbee, Diederick E., Kastelein, John J.P., Visseren, Frank L.J., Ntaios, George, Hatzitolios, Apostolos I., Savopoulos, Christos, Nieuwkerk, Pythia T., Stroes, Erik, Walters, Matthew, Higgins, Peter, Dawson, Jesse, Gresele, Paolo, Guglielmini, Giuseppe, Migliacci, Rino, Ezhov, Marat, Safarova, Maya, Balakhonova, Tatyana, Sato, Eiichi, Amaha, Mayuko, Nakamura, Tsukasa, Kapellas, Kostas, Jamieson, Lisa M., Skilton, Michael, Blumenthal, James A., Hinderliter, Alan, Sherwood, Andrew, Smith, Patrick J., van Agtmael, Michiel A., Reiss, Peter, van Vonderen, Marit G.A., Kiechl, Stefan, Klingenschmid, Gerhard, Sitzer, Matthias, Stehouwer, Coen D.A., Uthoff, Heiko, Zou, Zhi-Yong, Cunha, Ana R., Neves, Mario F., Witham, Miles D., Park, Hyun-Woong, Lee, Moo-Sik, Bae, Jang-Ho, Bernal, Enrique, Wachtell, Kristian, Kjeldsen, Sverre E., Olsen, Michael H., Preiss, David, Sattar, Naveed, Beishuizen, Edith, Huisman, Menno V., Espeland, Mark A., Schmidt, Caroline, Agewall, Stefan, Ok, Ercan, Aşçi, Gülay, de Groot, Eric, Grooteman, Muriel P.C., Blankestijn, Peter J., Bots, Michiel L., Sweeting, Michael J., Thompson, Simon G., Lorenz, Matthias W., For the PROG-IMT and the Proof-ATHERO Study Groups·2020·Circulation

Abstract

Background: To quantify the association between effects of interventions on carotid intima-media thickness (cIMT) progression and their effects on cardiovascular disease (CVD) risk. Methods: We systematically collated data from randomized, controlled trials. cIMT was assessed as the mean value at the common-carotid-artery; if unavailable, the maximum value at the common-carotid-artery or other cIMT measures were used. The primary outcome was a combined CVD end point defined as myocardial infarction, stroke, revascularization procedures, or fatal CVD. We estimated intervention effects on cIMT progression and incident CVD for each trial, before relating the 2 using a Bayesian meta-regression approach. Results: We analyzed data of 119 randomized, controlled trials involving 100 667 patients (mean age 62 years, 42% female). Over an average follow-up of 3.7 years, 12 038 patients developed the combined CVD end point. Across all interventions, each 10 μm/y reduction of cIMT progression resulted in a relative risk for CVD of 0.91 (95% Credible Interval, 0.87–0.94), with an additional relative risk for CVD of 0.92 (0.87–0.97) being achieved independent of cIMT progression. Taken together, we estimated that interventions reducing cIMT progression by 10, 20, 30, or 40 μm/y would yield relative risks of 0.84 (0.75–0.93), 0.76 (0.67–0.85), 0.69 (0.59–0.79), or 0.63 (0.52–0.74), respectively. Results were similar when grouping trials by type of intervention, time of conduct, time to ultrasound follow-up, availability of individual-participant data, primary versus secondary prevention trials, type of cIMT measurement, and proportion of female patients. Conclusions: The extent of intervention effects on cIMT progression predicted the degree of CVD risk reduction. This provides a missing link supporting the usefulness of cIMT progression as a surrogate marker for CVD risk in clinical trials.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1161/circulationaha.120.046361

Cites

202 of 202 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

2 retracted

Show all 202 references

Cited by

See all 452

Metadata

Authors
Willeit, P., Tschiderer, L., Allara, E., Reuber, K., Seekircher, L., Gao, L., Liao, X., Lonn, E., Gerstein, H. C., Yusuf, S., Brouwers, F. P., Asselbergs, F. W., van Gilst, W., Anderssen, S. A., Grobbee, D. E., Kastelein, J. J. P., Visseren, F. L. J., Ntaios, G., Hatzitolios, A. I., Savopoulos, C., Nieuwkerk, P. T., Stroes, E., Walters, M., Higgins, P., Dawson, J., Gresele, P., Guglielmini, G., Migliacci, R., Ezhov, M., Safarova, M., Balakhonova, T., Sato, E., Amaha, M., Nakamura, T., Kapellas, K., Jamieson, L. M., Skilton, M., Blumenthal, J. A., Hinderliter, A., Sherwood, A., Smith, P. J., van Agtmael, M. A., Reiss, P., van Vonderen, M. G. A., Kiechl, S., Klingenschmid, G., Sitzer, M., Stehouwer, C. D. A., Uthoff, H., Zou, Z.-Y., Cunha, A. R., Neves, M. F., Witham, M. D., Park, H.-W., Lee, M.-S., Bae, J.-H., Bernal, E., Wachtell, K., Kjeldsen, S. E., Olsen, M. H., Preiss, D., Sattar, N., Beishuizen, E., Huisman, M. V., Espeland, M. A., Schmidt, C., Agewall, S., Ok, E., Aşçi, G., de Groot, E., Grooteman, M. P. C., Blankestijn, P. J., Bots, M. L., Sweeting, M. J., Thompson, S. G., Lorenz, M. W., & Groups, F. T. P.-I. A. T. P.-A. S.
Venue
Circulation
Published
2020-08-18
Volume
142
Issue
7
Pages
621-642
ISSN
  • 0009-7322 (ISSN-L)
  • 1524-4539
OpenAlex
W3033917691
Cited by
452
References
202
FWCI
31.84
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Carotid Intima-Media Thickness Progression as Surrogate Marker for Cardiovascular Risk: Meta-Analysis of 119 Clinical Trials Involving 100 667 Patients. https://app.cochat.ai/papers/10.1161/circulationaha.120.046361
The paper
Willeit, P., Tschiderer, L., Allara, E., Reuber, K., Seekircher, L., Gao, L., Liao, X., Lonn, E., Gerstein, H. C., Yusuf, S., Brouwers, F. P., Asselbergs, F. W., van Gilst, W., Anderssen, S. A., Grobbee, D. E., Kastelein, J. J. P., Visseren, F. L. J., Ntaios, G., Hatzitolios, A. I., . . . Groups, F. T. P.-I. A. T. P.-A. S. (2020). Carotid Intima-Media Thickness Progression as Surrogate Marker for Cardiovascular Risk: Meta-Analysis of 119 Clinical Trials Involving 100 667 Patients. Circulation. https://doi.org/10.1161/circulationaha.120.046361

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.